1. Home
  2. Medical Research
  3. Silver Spring, MD
  4. Foundation for Rare Disease Research

Foundation for Rare Disease Research

Foundation for Rare Disease Research has an America's Best Score of 57 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • Silver Spring, MD
  • Tax-exempt since 2023
  • EIN: 92-0534021
ffrdr.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
57OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Foundation for Rare Disease Research is a 501(c)(3) organization, classified under Medical Research (NTEE H90). Contributions are tax-deductible.

12501 Prosperity Dr Ste 340, Silver Spring, MD 20904-1689

Among the 4 scored medical research organizations in Silver Spring, Foundation for Rare Disease Research holds 272.2 months of operating reserves (peer median 27.3 months), runs a typical yearly surplus of 225.0% (peers: surplus of 2.5%), and has grown spending 0.0% a year (peers: grown spending 7.6% a year).

In fiscal year 2025 it reported $339,269 in revenue and $104,396 in expenses, with contributions making up 46.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Discover, pursue and support the development of clinical diagnostics tools that can lead to cures for rare and orphan diseases by contributing to the advancement in research and development.

Main program · fiscal year 2025

  • The organization conducts research on rare diseases, including hereditary angioedema. During the year, the organization continued development of a method to measure the biomarker Bradykinin for use in clinical diagnosis and therapy monitoring. Research activities were carried out by contracted scientific service providers, and results were presented at professional meetings to support patient care… Read more

    The organization conducts research on rare diseases, including hereditary angioedema. During the year, the organization continued development of a method to measure the biomarker Bradykinin for use in clinical diagnosis and therapy monitoring. Research activities were carried out by contracted scientific service providers, and results were presented at professional meetings to support patient care and clinician education.

    $96,501 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 92¢ went to programs, 8¢ to management and 0¢ to fundraising.

  • Programs $96,501
  • Management $7,895
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score57 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves (reduced: more than 3 years of cash)10+ yrs; 57.9 mo in cash18.5 / 25
Financial balance (median margin)+225.0%0 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth0.0% / yr7.5 / 15
Track record3 years1.2 / 10
Debt load0.0% of assets10 / 10
Total57.2 → 57
Spending on programs
Not scored; America's Best needs 65%+
92%Meets

Compared with Silver Spring peers

MeasureThis organizationPeer median
Operating reserves10+ yrs27.3 mo
Typical margin+225.0%+2.5%
Spending growth0.0% / yr+7.6% / yr
Debt load0.0%3.3%

Peers: the 4 Silver Spring medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$339,269Fiscal year 20252022: $1,680,00020222023: $1,319,79920232024: $668,53220242025: $339,2692025
Expenses$104,396Fiscal year 20252022: $020222023: $2,38020232024: $1,533,14420242025: $104,3962025
Total assets$2,367,680Fiscal year 20252022: $1,680,00020222023: $2,997,41920232024: $2,132,80720242025: $2,367,6802025
Total liabilities$0Fiscal year 20252022: $020222023: $020232024: $020242025: $02025
Fiscal year ending December 2025
Revenue$339,269
Expenses$104,396
Net income$234,873
Net assets$2,367,680

Notable sources of revenue

Percent of total revenue
Contributions$158,542
Program services$0
Investment income$180,727
Other (net)$0

Assets / debt

Total assets$2,367,680
Total liabilities$0
Net assets$2,367,680

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$668,532
Expenses$1,533,144
Net income−$864,612
Net assets$2,132,807

Notable sources of revenue

Percent of total revenue
Contributions$366,000
Program services$0
Investment income$302,532
Other (net)$0

Assets / debt

Total assets$2,132,807
Total liabilities$0
Net assets$2,132,807

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$1,319,799
Expenses$2,380
Net income$1,317,419
Net assets$2,997,419

Notable sources of revenue

Percent of total revenue
Contributions$1,280,278
Program services$0
Investment income$39,521
Other (net)$0

Assets / debt

Total assets$2,997,419
Total liabilities$0
Net assets$2,997,419

Compensation

Officers and key employees$0
Share of expenses0.0%
Fiscal year ending December 2022
Revenue$1,680,000
Expenses$0
Net income$1,680,000
Net assets$1,680,000

Notable sources of revenue

Percent of total revenue
Contributions$1,680,000
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$1,680,000
Total liabilities$0
Net assets$1,680,000

Compensation

Officers and key employees$0
Share of expenses—

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?